Menu
Back to User profile » Dr Heather L Gelhorn
Papers published by Dr Heather L Gelhorn:
The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes
Gelhorn HL, Osumili B, Brown K, Ross MM, Schulz A, Fernandez G, Boye KS
Patient Preference and Adherence 2023, 17:793-805
Published Date: 22 March 2023
The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study
Gelhorn HL, Ross MM, Shinde S, Thieu VT, Boye KS
Patient Preference and Adherence 2022, 16:1897-1906
Published Date: 3 August 2022
Patient-Reported Outcomes and Impact of Type 2 Diabetes: A Cross-Sectional Study in the Kingdom of Saudi Arabia
Gelhorn HL, Boye KS, Shalhoub H, Matza LS, Jordan JB, Alhammad A, Anand SB, Ekhzaimy AA, Strizek A
Patient Preference and Adherence 2020, 14:2231-2242
Published Date: 10 November 2020
Patient and physician preferences for attributes of biologic medications for severe asthma
Gelhorn HL, Balantac Z, Ambrose CS, Chung YN, Stone B
Patient Preference and Adherence 2019, 13:1253-1268
Published Date: 25 July 2019
Preference for pharmaceutical formulation and treatment process attributes
Stewart KD, Johnston JA, Matza LS, Curtis SE, Havel HA, Sweetana SA, Gelhorn HL
Patient Preference and Adherence 2016, 10:1385-1399
Published Date: 27 July 2016
Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan
Gelhorn HL, Bacci ED, Poon JL, Boye KS, Suzuki S, Babineaux SM
Patient Preference and Adherence 2016, 10:1337-1348
Published Date: 25 July 2016
Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK
Gelhorn HL, Poon JL, Davies EW, Paczkowski R, Curtis SE, Boye KS
Patient Preference and Adherence 2015, 9:1611-1622
Published Date: 9 November 2015